Economic analysis of the global polio eradication initiative.
about
Can Economic Analysis Contribute to Disease Elimination and Eradication? A Systematic ReviewThe economics of malaria control and elimination: a systematic reviewSystematic review of studies evaluating the broader economic impact of vaccination in low and middle income countriesEnhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013Advocating for malaria elimination - learning from the successes of other infectious disease elimination programmes.The problems with polio: toward eradication.An epidemiological analysis of acute flaccid paralysis and its surveillance system in Iraq, 1997-2011.Vaccines and future global health needs.Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes.An economic analysis of poliovirus risk management policy options for 2013-2052The Prevalence and Severity of Joint Problems and Disability in Patients with Poliomyelitis in Urban India.World Health Organization's Innovative Direct Disbursement Mechanism for Payment of Grassroots Immunization Personnel and Operations in Nigeria: 2004-2015.Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.The human qualities needed to complete the global eradication of polio.The elimination of fox rabies from Europe: determinants of success and lessons for the futureThe potential impact of expanding target age groups for polio immunization campaigns.Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.Preeradication vaccine policy options for poliovirus infection and disease control.Polio endgame: the global introduction of inactivated polio vaccine.The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies.The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan - 2011-2013.Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers.Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.Lessons from polio eradication.Modeling and Managing the Risks of Measles and Rubella: A Global Perspective Part II.Modeling and Managing the Risks of Measles and Rubella: A Global Perspective, Part I.Polio endgame: the global switch from tOPV to bOPV.Framework for Optimal Global Vaccine Stockpile Design for Vaccine-Preventable Diseases: Application to Measles and Cholera Vaccines as Contrasting Examples.Economic considerations for the eradication endgame.Prioritizing polio.Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations.Elimination or eradication of viruses by means of immunisation.Modeling poliovirus risks and the legacy of polio eradication.Unintended consequences and the paradox of control: Management of emerging pathogens with age-specific virulence.Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine
P2860
Q27012936-28AABC9B-4FBB-4204-83D3-CC74B2C3AC13Q28072955-8598D7E8-1E73-4D0B-9336-4A4179812F86Q28277203-FC58E9C6-BFB4-401B-AB4B-4DC76A03748CQ28654939-560A2ED3-B6DA-47F0-8C06-E9101ACF4A48Q30391510-408F38B4-806F-40DC-B451-08606E5D3471Q33939084-70DBC024-8256-4CC9-AAF9-D622298D8B19Q34157010-51380436-F7B4-405F-8289-45A39CAD398CQ35137122-B53CADA7-6907-4958-BD35-A5970E8DC042Q35779660-415CBF3D-E4BF-4A19-9EF3-DB05C389A5E1Q35787304-1E7EDE32-B195-4B84-96CF-CE103B528F19Q35824749-F6E85139-D135-484D-9C48-4DADB04E262FQ36758719-703919E5-2C95-4766-9E11-8BE0AD647BB4Q36758750-82206D54-F9D7-4ADE-A122-8733D66D9486Q36775458-A5391194-0390-4F8F-831A-74834A1D2E25Q37037401-6110CD9E-8BD9-4E52-B7B8-6A6F54C3096CQ37568832-4282C38D-E047-4687-9B33-847CD250D769Q38006994-CA1F59B3-F967-4DC5-8793-EEDE08506756Q38086593-3C5DED82-897B-4F4F-A21D-2155C99743FEQ38322526-1CB63ED9-B871-46B4-B291-5F9A0932228CQ38561977-76B58C74-34F5-4049-AEF2-4C8DA1C911B1Q38662203-70F3E7F9-F624-46C9-AEFA-9D9E3C21C04AQ38729183-62901E29-C2A1-47E2-9A41-89A0BC5CC55BQ38754363-58B53A56-2248-42D7-BD8C-34DAD24D4EC2Q39161372-4832E412-5145-497F-AE14-21293FB434CDQ40226719-C77AA36C-27FA-4B4A-87AC-B799C365946FQ40611006-73820BDB-E778-45B8-8E22-BCB6A9569876Q40838379-EFB73406-A8DE-447D-893F-822A28E4B524Q42200855-19E59215-059E-4BA1-8611-047D1F9FFF9FQ42257588-22B1E5F9-0814-48C7-B21A-8D309FB99479Q46892437-921B90EA-9C91-4790-A6AB-DBB5292FA39AQ47556747-E2992E5E-C8C2-4597-A5FE-8F0E3117F8FDQ48602891-283D880D-BC7B-477D-A64F-36107BD05E6EQ53335042-4441DD46-E270-4D04-9E2E-FF9BA6AC62E2Q54239461-6742ED4C-1626-4535-961E-F798FF56491EQ58791913-955B1CAF-5B3C-4917-AE33-A915E5851432
P2860
Economic analysis of the global polio eradication initiative.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Economic analysis of the global polio eradication initiative.
@en
Economic analysis of the global polio eradication initiative.
@nl
type
label
Economic analysis of the global polio eradication initiative.
@en
Economic analysis of the global polio eradication initiative.
@nl
prefLabel
Economic analysis of the global polio eradication initiative.
@en
Economic analysis of the global polio eradication initiative.
@nl
P2093
P50
P1433
P1476
Economic analysis of the global polio eradication initiative
@en
P2093
Jennifer Linkins
R Bruce Aylward
Roland W Sutter
Stephen L Cochi
Steven G F Wassilak
P304
P356
10.1016/J.VACCINE.2010.10.026
P407
P577
2010-10-26T00:00:00Z